OGESTREL 0.5/50-21 Comprehensive clinical and safety monograph for OGESTREL 0.5/50-21 (OGESTREL 0.5/50-21). | Oral Contraceptive | OGESTREL 0.5/50-21 | caution |
OGESTREL 0.5/50-28 Comprehensive clinical and safety monograph for OGESTREL 0.5/50-28 (OGESTREL 0.5/50-28). | Oral Contraceptive | OGESTREL 0.5/50-28 | caution |
OGIVRI Comprehensive clinical and safety monograph for OGIVRI (OGIVRI). | Vaccine (Influenza) | OGIVRI | caution |
OGSIVEO Comprehensive clinical and safety monograph for OGSIVEO (OGSIVEO). | Antineoplastic (Multi-kinase Inhibitor) | OGSIVEO | caution |
OHTUVAYRE Comprehensive clinical and safety monograph for OHTUVAYRE (OHTUVAYRE). | Ophthalmic Corticosteroid | OHTUVAYRE | caution |
OJEMDA Comprehensive clinical and safety monograph for OJEMDA (OJEMDA). | RAF Kinase Inhibitor | OJEMDA | caution |
OJJAARA Comprehensive clinical and safety monograph for OJJAARA (OJJAARA). | JAK2 Kinase Inhibitor | OJJAARA | caution |
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE CNS depressants may enhance sedative effects Can cause metabolic changes including weight gain hyperlipidemia and hyperglycemia. | Atypical Antipsychotic | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | safe |
OLAPARIB Comprehensive clinical and safety monograph for OLAPARIB (OLAPARIB). | PARP Inhibitor | OLAPARIB | caution |
OLEPTRO Comprehensive clinical and safety monograph for OLEPTRO (OLEPTRO). | Triptan | OLEPTRO | caution |
OLINVYK Comprehensive clinical and safety monograph for OLINVYK (OLINVYK). | Opioid Analgesic | OLINVYK | caution |
OLMESARTAN MEDOXOMIL NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus. | ARB | OLMESARTAN MEDOXOMIL | avoid |
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus. | ARB | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | avoid |
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus. | ARB | OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE | avoid |
OLOPATADINE HYDROCHLORIDE No significant drug interactions For ophthalmic use only may cause mild transient burning or stinging. | Antihistamine / Mast Cell Stabilizer | OLOPATADINE HYDROCHLORIDE | safe |
OLPRUVA Comprehensive clinical and safety monograph for OLPRUVA (OLPRUVA). | Urea Cycle Disorder Agent | OLPRUVA | caution |
OLUMIANT Comprehensive clinical and safety monograph for OLUMIANT (OLUMIANT). | JAK Kinase Inhibitor | OLUMIANT | caution |
OLUX Comprehensive clinical and safety monograph for OLUX (OLUX). | Topical Corticosteroid | OLUX | caution |
OLUX E Comprehensive clinical and safety monograph for OLUX E (OLUX E). | Topical Corticosteroid | OLUX E | caution |
OLYSIO Comprehensive clinical and safety monograph for OLYSIO (OLYSIO). | Hepatitis C NS3/4A Protease Inhibitor | OLYSIO | caution |
OMACOR Comprehensive clinical and safety monograph for OMACOR (OMACOR). | Antilipemic | OMACOR | caution |
OMECLAMOX-PAK Comprehensive clinical and safety monograph for OMECLAMOX-PAK (OMECLAMOX-PAK). | Proton Pump Inhibitor Combination | OMECLAMOX-PAK | caution |
OMEGA-3-ACID ETHYL ESTERS Comprehensive clinical and safety monograph for OMEGA-3-ACID ETHYL ESTERS (OMEGA-3-ACID ETHYL ESTERS). | Lipid-Regulating Agent | OMEGA-3-ACID ETHYL ESTERS | caution |
OMEGAVEN Comprehensive clinical and safety monograph for OMEGAVEN (OMEGAVEN). | Intravenous Nutritional Supplement | OMEGAVEN | caution |
OMEPRAZOLE Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use. | Proton Pump Inhibitor | OMEPRAZOLE | safe |
OMEPRAZOLE AND SODIUM BICARBONATE Can decrease the levels of many drugs by increasing urinary pH Can cause metabolic alkalosis and fluid overload. | Alkalinizing Agent | OMEPRAZOLE AND SODIUM BICARBONATE | safe |
OMEPRAZOLE MAGNESIUM Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use. | Proton Pump Inhibitor | OMEPRAZOLE MAGNESIUM | safe |
OMIDRIA Comprehensive clinical and safety monograph for OMIDRIA (OMIDRIA). | Ophthalmic NSAID and Mydriatic Combination | OMIDRIA | caution |
OMLONTI Comprehensive clinical and safety monograph for OMLONTI (OMLONTI). | Ophthalmic Antiglaucoma Agent | OMLONTI | caution |
OMLYCLO Comprehensive clinical and safety monograph for OMLYCLO (OMLYCLO). | Ophthalmic Immunosuppressant | OMLYCLO | caution |
OMNARIS Comprehensive clinical and safety monograph for OMNARIS (OMNARIS). | Nasal Corticosteroid | OMNARIS | caution |
OMNICEF Comprehensive clinical and safety monograph for OMNICEF (OMNICEF). | Cephalosporin Antibiotic | OMNICEF | caution |
OMNIPAQUE 12 Comprehensive clinical and safety monograph for OMNIPAQUE 12 (OMNIPAQUE 12). | Radiographic Contrast Agent | OMNIPAQUE 12 | caution |
OMNIPAQUE 140 Comprehensive clinical and safety monograph for OMNIPAQUE 140 (OMNIPAQUE 140). | Radiographic Contrast Agent | OMNIPAQUE 140 | caution |
OMNIPAQUE 180 Comprehensive clinical and safety monograph for OMNIPAQUE 180 (OMNIPAQUE 180). | Radiographic Contrast Agent | OMNIPAQUE 180 | caution |
OMNIPAQUE 210 Comprehensive clinical and safety monograph for OMNIPAQUE 210 (OMNIPAQUE 210). | Radiographic Contrast Agent | OMNIPAQUE 210 | caution |
OMNIPAQUE 240 Comprehensive clinical and safety monograph for OMNIPAQUE 240 (OMNIPAQUE 240). | Radiographic Contrast Agent | OMNIPAQUE 240 | caution |
OMNIPAQUE 300 Comprehensive clinical and safety monograph for OMNIPAQUE 300 (OMNIPAQUE 300). | Radiographic Contrast Agent | OMNIPAQUE 300 | caution |
OMNIPAQUE 350 Comprehensive clinical and safety monograph for OMNIPAQUE 350 (OMNIPAQUE 350). | Radiographic Contrast Agent | OMNIPAQUE 350 | caution |
OMNIPAQUE 70 Comprehensive clinical and safety monograph for OMNIPAQUE 70 (OMNIPAQUE 70). | Radiographic Contrast Agent | OMNIPAQUE 70 | caution |
OMNIPAQUE 9 Comprehensive clinical and safety monograph for OMNIPAQUE 9 (OMNIPAQUE 9). | Radiographic Contrast Agent | OMNIPAQUE 9 | caution |
OMNIPEN (AMPICILLIN) Probenecid decreases renal tubular secretion of ampicillin Allopurinol may increase the incidence of skin rashes Serious and occasionally fatal hypersensitivity reactions have been reported. | Penicillin Antibiotic | OMNIPEN (AMPICILLIN) | safe |
OMNIPEN-N Comprehensive clinical and safety monograph for OMNIPEN-N (OMNIPEN-N). | Penicillin Antibiotic | OMNIPEN-N | caution |
OMNISCAN Comprehensive clinical and safety monograph for OMNISCAN (OMNISCAN). | Gadolinium-Based MRI Contrast Agent | OMNISCAN | caution |
OMNITROPE Comprehensive clinical and safety monograph for OMNITROPE (OMNITROPE). | Growth Hormone | OMNITROPE | caution |
OMONTYS Comprehensive clinical and safety monograph for OMONTYS (OMONTYS). | Erythropoiesis-Stimulating Agent | OMONTYS | caution |
OMONTYS PRESERVATIVE FREE Comprehensive clinical and safety monograph for OMONTYS PRESERVATIVE FREE (OMONTYS PRESERVATIVE FREE). | Erythropoiesis-Stimulating Agent | OMONTYS PRESERVATIVE FREE | caution |
OMTRYG Comprehensive clinical and safety monograph for OMTRYG (OMTRYG). | HMG-CoA Reductase Inhibitor (Statin) | OMTRYG | caution |
OMVOH Comprehensive clinical and safety monograph for OMVOH (OMVOH). | Interleukin-23 Antagonist | OMVOH | caution |
ONA-MAST Comprehensive clinical and safety monograph for ONA-MAST (ONA-MAST). | Botulinum Toxin | ONA-MAST | caution |
